Evolution of the Average Target: Santhera Pharmaceuticals Holding AG

Evolution of the Target Price: Santhera Pharmaceuticals Holding AG

Changes in Analyst Recommendations: Santhera Pharmaceuticals Holding AG

944526.ZRJ2n-UVuLIekSXBWRhZVKhJR_aPFQeE8ggVoE-vi_E.Jlgd25VljIp23RfwClIWEeYjGJHKcHX9n3Eg-BWWupIRKh3eqkD9w0zobA~e7392adb3e0ffef052c350cd4408f556

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +65.26%
-3.13%
+11.27%
-7.96%
-12.14%
+53.72%
+45.94%
- - -15.87%
+34.68%
Average +19.09%
Weighted average by Cap. -0.15%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.64CHF
Average target price
27.50CHF
Spread / Average Target
+65.26%
High Price Target
30.00CHF
Spread / Highest target
+80.29%
Low Price Target
25.00CHF
Spread / Lowest Target
+50.24%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.64CHF
Average target price
27.50CHF
Spread / Average Target
+65.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SANN Stock
  4. Consensus Santhera Pharmaceuticals Holding AG